You are on page 1of 37

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E.

Burcao RMT, MSMT©


1. Explain the mechanism of autoimmunity.
2. Describe the general characteristics and
clinical manifestations of autoimmune
disorders.
3. Identify the autoantibodies associated with
each autoimmune disorder.

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 represents a breakdown of the immune system’s ability
to discriminate between self and nonself
 the body’s immune system becomes misdirected,
attacking the organs it was designed to protect
 Involves either MHC class I or class II but most
especially class II

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Occurrence of an immune response resulting in the
production of either antibody and/or sensitized
lymphoid cells capable of reacting with normal body
constituents
 All autoimmune diseases involve antigen-antibody
complexes (immune complexes)

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
1. Release of sequestered antigens (hidden antigens;
recognized after trauma)
2. Self-antigens are slightly altered and the body makes
antibodies to these self-antigens
3. Cross-reacting (heterophile) or closely related
antibody
4. The spontaneous emergence of clones cells capable
of making immune response to one’s own tissues
5. Deficiency of T suppressor cells

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
a. Increase serum gamma globulin
b. occurrence of different autoantibodies detected in
serum
c. decreased complement concentration in serum
d. absence of CD8+ lymphocytes
e. immunoglobulin and complement deposits in
arterial walls and basement membranes
f. lesions detected by biopsy

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT© 6
 Anti-nuclear antibodies
◦ Antibody produced to different components of the
nucleus during the course of several autoimmune
diseases
◦ Associated with systemic lupus erythematosus (SLE),
mixed connective tissue disease (MCTD), and
rheumatoid arthritis

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Anti-nuclear antibodies
◦ Techniques used: agglutination, indirect
immunofluorescence, and enzyme immunoassay

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Diffuse or homogenous: evenly stains the nuclei and is
associated with anti-DNA antibody and histones
◦ Solid, diffuse
◦ Characterizes:
 Anti-deoxyribonucleoprotein (DNP) antibodies
(i.e. antibodies to nDNA, dsDNA, ssDNA, DNP or
histones)

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Diffuse or homogenous

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Diffuse or homogenous:
◦ Associated with:
 Typically seen in rheumatoid arthritis
 High titers of homogenous ANA are suggestive of SLE
 Low titers may be found in SLE, RA, Sjogren’s
syndrome and Mixed Connective Tissue Disease
(MCTD)

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Peripheral: stains the edge of the nuclei and is associated
with anti-DNA antibody and anti-lamins (proteins found in
the nuclear membrane) antibody
◦ Ring, membranous, shaggy or thread
◦ Pattern results from antibodies to DNA
◦ Due to: Anti-dsDNA
◦ Associated with:
 Active stage of SLE
 Sjogren’s syndrome
Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Peripheral

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Speckled: numerous evenly distributed stained
speckles within the nuclei associated with antibodies to
extractable nuclear antigens – nuclear
ribonucleoprotein (RNP) and anti- Smith (Sm)
◦ Pattern occurs in the presence of antibody to any
extractable nuclear antigen devoid of DNA or histone

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Speckled
◦ Due to:
 Anti-extractable nuclear Ag (ENA)
 Anti-Smith (Sm)
 Anti-ribonucleoprotein (RNP): has been found in
patients with wide variety of rheumatic diseases
including SLE, RA, Sjogren’s syndrome, progressive
systemic sclerosis, MCTD and dermatomyositis

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Speckled

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Nucleolar: stains two or three large fluorescent areas
within the nucleus and is associated with anti-RNP
antibody
◦ Reflects: Antibody to nucleolar RNA
◦ Present in about 50% patients with scleroderma
(progressive systemic sclerosis), Sjogren’s syndrome
and in SLE

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Nucleolar

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Centromere: stains as a discrete speckled pattern due to
anticentromere antibody
◦ Antibody reacts with the centromeric chromatin of
metaphase and interphase cells
◦ Due to:
 Anti-centromere antibody (ACA)
◦ Appears to be highly selective for CREST variant of
progressive systemic sclerosis

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Centromeres

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Rheumatoid factor
◦ Rheumatoid factor (RF) is an anti-antibody, typically
IgM, that binds to the Fc portion of abnormal IgG
◦ Also, noted in chronic hepatitis, SLE and syphilis.
 Cryoglobulins
◦ Proteins that reversibly precipitate at 4°C
◦ Associated with autoimmune diseases such as
vasculitis, glomerulonephritis, SLE, RA, and Sjogren’s
syndrome

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Chronic inflammatory autoimmune disease
characterized by the presence of ANA
 Symptoms may include swelling of the joints,
erythematous rash and deposition of immune
complexes in the kidneys
• Pathologic features:
➢ chronic, inflammatory, multiorgan disorder
➢ butterfly rash
➢Renal involvement
➢ CNS manifestations
Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Laboratory diagnosis of SLE
◦ 1) Demonstration of LE cell
 Neutrophil has engulfed the antibody-coated nucleus of
another neutrophil
◦ 2) Detection of antinuclear antibodies
 ds-DNA antibodies : Most specific to SLE this can be
detected by FANA, Crithidial and RIA testing.
 Anti-histone antibody: Drug induced Lupus
 Anti-Sm antibody: Specific for Lupus because it is not
found in any other autoimmune diseases but only 7- 25%
with Lupus is positive with the antibody.

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Laboratory diagnosis of SLE
◦ 1) Demonstration of LE cell

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Autoimmune disease that affects the synovial
membrane of multiple joints
 Characterized by the presence of an autoantibody
called rheumatoid factor (RF)
 Pathologic features:
◦ chronic, inflammatory joint disease with lesions

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Laboratory diagnosis of RA: Based on the detection of
RF
◦ 1) Sheep cell agglutination test: Rose-Waaler Test à
tannic acid-treated sRBCs are coated with rabbit IgG
◦ 2) Latex fixation test: Singer and Plotz
◦ 3) Sensitized alligator erythrocyte test: Cohen et.al
◦ 4) Bentonite flocculation test: Bloch and Bunim
◦ Note: Anti-cyclic citrullinated peptide antibody (anti-
CCP)

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 An inflammation of salivary and lacrimal glands
causing dryness of mouth and eyes
 Pathologic features:
◦ chronic inflammatory disease: exocrine glands
◦ patients have dry eyes, dry mouth, dry nose, larynx
and bronchi

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Laboratory findings
◦ Polyclonal hypergammaglobulinemia;
◦ autoantibodies against the salivary glands;
◦ positive RF,
◦ ANA (speckled or diffuse pattern), anti-SSA, and
anti-SSB

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©
 Increased rate of RBC destruction
 Results in normocytic, normochromic anemia
 Autoantibody is directed against RBC antigens
 Laboratory findings
◦ positive direct antiglobulin test
◦ sometimes cold agglutinins

Prepared by: Nhoelyn E. Burcao RMT, MSMT© Prepared by: Nhoelyn E. Burcao RMT, MSMT©

You might also like